422 related articles for article (PubMed ID: 16424859)
1. High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents--United States, 2005-06 influenza season.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2006 Jan; 55(2):44-6. PubMed ID: 16424859
[TBL] [Abstract][Full Text] [Related]
2. Influenza antiviral prescribing practices during the 2007-08 and 2008-09 influenza seasons in the setting of increased resistance to oseltamivir among circulating influenza viruses.
Dharan NJ; Beekmann SE; Fiore A; Finelli L; Uyeki TM; Polgreen PM; Fry AM
Antiviral Res; 2010 Nov; 88(2):182-6. PubMed ID: 20739002
[TBL] [Abstract][Full Text] [Related]
3. Antiviral management of seasonal and pandemic influenza.
Hayden FG; Pavia AT
J Infect Dis; 2006 Nov; 194 Suppl 2():S119-26. PubMed ID: 17163384
[TBL] [Abstract][Full Text] [Related]
4. Influenza: evolving strategies in treatment and prevention.
Lynch JP; Walsh EE
Semin Respir Crit Care Med; 2007 Apr; 28(2):144-58. PubMed ID: 17458769
[TBL] [Abstract][Full Text] [Related]
5. Antivirals and influenza: frequency of resistance.
Monto AS
Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S110-2. PubMed ID: 18820569
[TBL] [Abstract][Full Text] [Related]
6. The genesis and spread of reassortment human influenza A/H3N2 viruses conferring adamantane resistance.
Simonsen L; Viboud C; Grenfell BT; Dushoff J; Jennings L; Smit M; Macken C; Hata M; Gog J; Miller MA; Holmes EC
Mol Biol Evol; 2007 Aug; 24(8):1811-20. PubMed ID: 17522084
[TBL] [Abstract][Full Text] [Related]
7. Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors.
Hurt AC; Ho HT; Barr I
Expert Rev Anti Infect Ther; 2006 Oct; 4(5):795-805. PubMed ID: 17140356
[TBL] [Abstract][Full Text] [Related]
8. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
[TBL] [Abstract][Full Text] [Related]
9. Update: influenza activity - United States, September 28, 2008--January 31, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Feb; 58(5):115-9. PubMed ID: 19214161
[TBL] [Abstract][Full Text] [Related]
10. Increased adamantane resistance in influenza A(H3) viruses in Australia and neighbouring countries in 2005.
Barr IG; Hurt AC; Iannello P; Tomasov C; Deed N; Komadina N
Antiviral Res; 2007 Feb; 73(2):112-7. PubMed ID: 16963130
[TBL] [Abstract][Full Text] [Related]
11. Adamantane resistance in influenza A(H1) viruses increased in 2007 in South East Asia but decreased in Australia and some other countries.
Barr IG; Deng YM; Iannello P; Hurt AC; Komadina N
Antiviral Res; 2008 Nov; 80(2):200-5. PubMed ID: 18611414
[TBL] [Abstract][Full Text] [Related]
12. Dynamics of antiviral-resistant influenza viruses in the Netherlands, 2005-2008.
Jonges M; van der Lubben IM; Dijkstra F; Verhoef L; Koopmans M; Meijer A
Antiviral Res; 2009 Sep; 83(3):290-7. PubMed ID: 19591877
[TBL] [Abstract][Full Text] [Related]
13. Adamantane resistance in circulating human influenza A viruses from Alberta, Canada (1970-2007).
Pabbaraju K; Ho KC; Wong S; Shokoples S; Pang XL; Fonseca K; Fox JD
Antiviral Res; 2008 Aug; 79(2):81-6. PubMed ID: 18258311
[TBL] [Abstract][Full Text] [Related]
14. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States.
Bright RA; Shay DK; Shu B; Cox NJ; Klimov AI
JAMA; 2006 Feb; 295(8):891-4. PubMed ID: 16456087
[TBL] [Abstract][Full Text] [Related]
15. Emergence of adamantane-resistant influenza A(H3N2) viruses in Hong Kong between 1997 and 2006.
Tang JW; Ngai KL; Wong JC; Lam WY; Chan PK
J Med Virol; 2008 May; 80(5):895-901. PubMed ID: 18360910
[TBL] [Abstract][Full Text] [Related]
16. Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide.
Deyde VM; Xu X; Bright RA; Shaw M; Smith CB; Zhang Y; Shu Y; Gubareva LV; Cox NJ; Klimov AI
J Infect Dis; 2007 Jul; 196(2):249-57. PubMed ID: 17570112
[TBL] [Abstract][Full Text] [Related]
17. Antiviral treatment and prophylaxis of influenza in primary care: German recommendations.
Wutzler P; Kossow KD; Lode H; Ruf BR; Scholz H; Vogel GE;
J Clin Virol; 2004 Oct; 31(2):84-91. PubMed ID: 15364262
[TBL] [Abstract][Full Text] [Related]
18. Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996-2007.
Tashiro M; McKimm-Breschkin JL; Saito T; Klimov A; Macken C; Zambon M; Hayden FG;
Antivir Ther; 2009; 14(6):751-61. PubMed ID: 19812437
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus.
Rungrotmongkol T; Intharathep P; Malaisree M; Nunthaboot N; Kaiyawet N; Sompornpisut P; Payungporn S; Poovorawan Y; Hannongbua S
Biochem Biophys Res Commun; 2009 Jul; 385(3):390-4. PubMed ID: 19463784
[TBL] [Abstract][Full Text] [Related]
20. Antivirals for influenza: historical perspectives and lessons learned.
Hayden FG
Antiviral Res; 2006 Sep; 71(2-3):372-8. PubMed ID: 16815563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
